Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.91% |
| 2 | Technology | 12.35% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.99% |
| 5 | Consumer Staples | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNBKA
1226
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $12.9M | 0.01% |
147,749
+16,748
| +13% | +$1.42M |
|
|
SAND
1227
DELISTED
Sandstorm Gold
SAND
| $12.9M | 0.01% |
2,283,700
+1,683,460
| +280% | +$10.2M |
|
|
PFNX
1228
DELISTED
Pfenex Inc.
PFNX
| $12.9M | 0.01% |
1,523,805
+119,200
| +8% | +$864K |
|
|
ESGR
1229
DELISTED
Enstar Group
ESGR
| $12.8M | 0.01% |
67,600
+20,600
| +44% | +$3.69M |
|
|
ALLK
1230
DELISTED
Allakos
ALLK
| $12.8M | 0.01% |
+162,700
| New | +$10.7M |
|
|
RVI
1231
DELISTED
Retail Value Inc. Common Shares
RVI
| $12.8M | 0.01% |
3,758,454
+2,682,086
| +249% | +$9.06M |
|
1232
Brighthouse Financial
BHF
$3.56B
| $12.8M | 0.01% |
315,200
+156,600
| +99% | +$5.83M |
|
|
CAMP
1233
DELISTED
CalAmp Corp.
CAMP
| $12.7M | 0.01% |
48,113
+656
| +1% | +$162K |
|
1234
Arthur J. Gallagher & Co
AJG
$64.1B
| $12.7M | 0.01% |
142,300
-94,400
| -40% | -$8.49M |
|
1235
Energy Transfer Partners
ET
$70.1B
| $12.7M | 0.01% |
974,378
-2,567,007
| -72% | -$35.8M |
|
1236
Brown-Forman Class B
BF.B
$13.2B
| $12.7M | 0.01% |
202,996
-190,438
| -48% | -$11.1M |
|
|
FFIC
1237
DELISTED
Flushing Financial
FFIC
| $12.7M | 0.01% |
630,360
+36,500
| +6% | +$746K |
|
1238
Standard BioTools
LAB
$340M
| $12.7M | 0.01% |
2,745,360
+222,560
| +9% | +$1.75M |
|
1239
UMB Financial
UMBF
$11.1B
| $12.7M | 0.01% |
196,800
+73,900
| +60% | +$4.78M |
|
|
ATH
1240
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $12.7M | 0.01% |
300,973
-182,027
| -38% | -$7.46M |
|
1241
Arrow Financial
AROW
$659M
| $12.6M | 0.01% |
425,243
+20,842
| +5% | +$601K |
|
|
BFIN
1242
DELISTED
BankFinancial
BFIN
| $12.6M | 0.01% |
1,060,200
+38,400
| +4% | +$482K |
|
|
PTNR
1243
DELISTED
Partner Communications
PTNR
| $12.6M | 0.01% |
2,678,550
-100
| -0% | -$426 |
|
1244
Addus HomeCare
ADUS
$2.16B
| $12.6M | 0.01% |
159,020
-164,580
| -51% | -$13.3M |
|
|
SPNS
1245
DELISTED
Sapiens International
SPNS
| $12.6M | 0.01% |
640,400
+40,900
| +7% | +$714K |
|
1246
Central Garden & Pet Co
CENT
$2.69B
| $12.6M | 0.01% |
537,731
-75,394
| -12% | -$1.63M |
|
|
BPYU
1247
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $12.6M | 0.01% |
616,559
+121,759
| +25% | +$2.35M |
|
1248
Tootsie Roll Industries
TR
$2.93B
| $12.5M | 0.01% |
415,448
-4,796
| -1% | -$145K |
|
|
RAVN
1249
DELISTED
Raven Industries Inc
RAVN
| $12.5M | 0.01% |
373,100
-11,016
| -3% | -$370K |
|
|
ARD
1250
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $12.5M | 0.01% |
795,090
+226,800
| +40% | +$3.89M |
|
Similar funds
Renaissance Technologies's Q3 2019 Portfolio in Review
As of Q3 2019, Renaissance Technologies held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Renaissance Technologies's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Renaissance Technologies added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Renaissance Technologies's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Renaissance Technologies fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Renaissance Technologies's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Renaissance Technologies opened 406 new positions and closed 522 in Q3 2019.
- Renaissance Technologies's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.